119 related articles for article (PubMed ID: 7619921)
1. Developments in the treatment of leukaemias and lymphomas.
Ann Hematol; 1995 Jun; 68(3 Suppl):1-8. PubMed ID: 7619921
[No Abstract] [Full Text] [Related]
2. [New analogs of deoxyadenosine for treatment of lymphoid malignancies].
Robak T
Przegl Lek; 1992; 49(10):355-8. PubMed ID: 1364050
[No Abstract] [Full Text] [Related]
3. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
Saven A
Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
[No Abstract] [Full Text] [Related]
4. Current trends in chemotherapy of leukaemias lymphomas and multiple myeloma.
Kasili EG
East Afr Med J; 1976 Sep; 53(9):554-9. PubMed ID: 1009883
[No Abstract] [Full Text] [Related]
5. [Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
Itälä M; Remes K
Duodecim; 2001; 117(2):162-9. PubMed ID: 12092367
[No Abstract] [Full Text] [Related]
6. Purine analogs in leukemia.
Lamanna N; Weiss M
Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
[No Abstract] [Full Text] [Related]
7. CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?
Bolaños-Meade J; Sarkodee-Adoo C; Khanwani SL
Am J Hematol; 2002 Oct; 71(2):139. PubMed ID: 12353319
[No Abstract] [Full Text] [Related]
8. [Clinical pharmacology of fludarabine].
Robak T; Drzewoski J
Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):942-4. PubMed ID: 1845714
[No Abstract] [Full Text] [Related]
9. Perspectives on purine analogues.
Cheson BD
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
[TBL] [Abstract][Full Text] [Related]
10. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
Pawelski S
Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
Lefrère F; Lévy V; François S; Delarue R; Ifrah N; Tilly H; Valensi F; Troussard X; Varet B; Hermine O
Leukemia; 2004 Nov; 18(11):1924-5. PubMed ID: 15385943
[No Abstract] [Full Text] [Related]
12. Fludarabine in lymphoproliferative malignancies: a single-centre experience.
Prabhash K; Vikram GS; Nair R; Sengar M; Gujral S; Bakshi A; Gupta S; Parikh PM
Natl Med J India; 2008; 21(4):171-4. PubMed ID: 19267037
[TBL] [Abstract][Full Text] [Related]
13. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Dearden CE; Matutes E; Catovsky D
Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in leukemia.
Croce C
Clin Adv Hematol Oncol; 2006 Aug; 4(8):577-8. PubMed ID: 17099614
[No Abstract] [Full Text] [Related]
15. Introduction: evolution of targeted and multifunctional agents for leukemias and lymphomas.
Tallman MS
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S1. PubMed ID: 18760703
[No Abstract] [Full Text] [Related]
16. Fludarabine-related myeloid leukemia.
Astrow AB
J Clin Oncol; 2003 Oct; 21(19):3709; author reply 3709-10. PubMed ID: 14512411
[No Abstract] [Full Text] [Related]
17. Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma.
Grigg A; Bardy P; Byron K; Seymour JF; Szer J
Bone Marrow Transplant; 1999 Jan; 23(2):107-10. PubMed ID: 10197793
[TBL] [Abstract][Full Text] [Related]
18. Richter's syndrome--the downside of fludarabine?
Hamblin TJ
Leuk Res; 2005 Oct; 29(10):1103-4. PubMed ID: 16111529
[No Abstract] [Full Text] [Related]
19. Fludarabine for chronic lymphocytic leukemia.
Erman M; Celik I; Tekuzman G
N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
[No Abstract] [Full Text] [Related]
20. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
